10-Q: Best Buy Q3 Earnings Hit by Health Unit Impairments, Restructuring
Quarterly Report
Best Buy reported a revenue increase in the third quarter and first nine months of fiscal 2026, but net earnings and diluted EPS declined significantly due to substantial goodwill and intangible asset impairments related to its Best Buy Health business and increased restructuring charges.
Summary
- Revenue for the three months ended November 1, 2025, increased by 2.4% to $9.672 billion, with comparable sales growing 2.7%.
- Revenue for the nine months ended November 1, 2025, increased by 1.1% to $27.877 billion, with comparable sales growing 1.2%.
- Net earnings for the third quarter decreased to $140 million from $273 million in the prior year.
- Diluted EPS for the third quarter decreased to $0.66 from $1.26 in the prior year.
- Net earnings for the nine months decreased to $528 million from $810 million in the prior year.
- Diluted EPS for the nine months decreased to $2.48 from $3.73 in the prior year.
- Goodwill and intangible asset impairments of $171 million were recorded in the third quarter and first nine months of fiscal 2026, primarily related to the Best Buy Health reporting unit.
- Restructuring charges for the nine months increased significantly to $218 million from $4 million in the prior year, driven by labor and store optimization and Best Buy Health initiatives.
- Domestic segment comparable sales grew 2.4% in Q3, driven by computing, gaming, and mobile phones, but offset by declines in home theater and appliances.
- International segment comparable sales grew 6.3% in Q3, driven by computing, mobile phones, and gaming.
- Cash provided by operating activities increased to $684 million for the nine months, up from $561 million in the prior year.
- The company repurchased $34 million of common stock in Q3 and $201 million for the nine months, with $3.1 billion remaining on its share repurchase program.
Sentiment
Score: 4
Explanation: While revenue and comparable sales showed growth, the significant decline in net earnings and diluted EPS, primarily driven by substantial goodwill and intangible asset impairments related to Best Buy Health and increased restructuring charges, indicates underlying operational challenges and a negative impact on profitability. The strategic adjustments are necessary but reflect past underperformance in certain areas.
Positives
- Consolidated revenue increased by 2.4% in the third quarter and 1.1% for the first nine months of fiscal 2026.
- Comparable sales grew by 2.7% in the third quarter and 1.2% for the first nine months, driven by new technology innovation, omni-channel customer experience, and strong vendor partnerships.
- Domestic segment comparable sales saw growth in computing, gaming, and mobile phones.
- International segment revenue increased by 6.1% in the third quarter and 5.7% for the first nine months, with comparable sales up 6.3% and 4.5% respectively.
- International segment adjusted operating income rate increased due to increased leverage from higher sales volumes and favorable supply chain costs.
- Cash provided by operating activities increased to $684 million for the nine months ended November 1, 2025, compared to $561 million in the prior year.
- The company maintains a $1.25 billion five-year senior unsecured revolving credit facility with no outstanding borrowings.
- The company continues to return capital to shareholders through dividends and share repurchases, with $3.1 billion remaining on its share repurchase program.
Negatives
- Net earnings decreased significantly to $140 million in the third quarter of fiscal 2026 from $273 million in the prior year, and to $528 million for the nine months from $810 million.
- Diluted EPS decreased to $0.66 in the third quarter of fiscal 2026 from $1.26 in the prior year, and to $2.48 for the nine months from $3.73.
- Operating income rate decreased in the third quarter and first nine months of fiscal 2026, primarily due to goodwill and intangible asset impairments and higher restructuring charges for the nine-month period.
- Goodwill and intangible asset impairments of $171 million were recorded in the third quarter and first nine months of fiscal 2026, primarily related to the Best Buy Health reporting unit, reflecting downward revisions of revenue growth and margin rates due to pressures in Medicaid and Medicare Advantage markets.
- Restructuring charges for the nine months ended November 1, 2025, increased substantially to $218 million from $4 million in the prior year, driven by labor and store optimization and Best Buy Health initiatives.
- Domestic segment gross profit rate decreased in the third quarter due to lower product margin rates, an unfavorable sales mix, and increased personalized promotional offers.
- Comparable sales declined in home theater, appliances, drones, and Best Buy Health service offerings within the Domestic segment.
- Cash and cash equivalents decreased to $923 million as of November 1, 2025, from $1,578 million as of February 1, 2025.
- Total equity decreased to $2,653 million as of November 1, 2025, from $2,808 million as of February 1, 2025.
Risks
- Macroeconomic pressures, including recession, inflation, fluctuations in foreign currency exchange rates, and geopolitical events (Eastern Europe and Middle East conflicts, supply chain disruptions).
- Susceptibility of products to technological advancements, product life cycle fluctuations, and changes in consumer preferences.
- Intense competition from multi-channel retailers, e-commerce businesses, technology service providers, traditional store-based retailers, and vendors.
- Challenges in attracting and retaining qualified employees and changes in market compensation rates.
- Risks associated with expansion into health and new products, services, and technologies, particularly given the Best Buy Health impairments.
- Reliance on key vendors and mobile network carriers, including product availability.
- Inability of vendors or service providers to perform components of the supply chain.
- Risks associated with vendors that source products outside of the U.S., including tariffs and trade wars (China sourcing initiative).
- Reliance on information technology systems and vulnerability to cyber-attacks, privacy, or security breaches.
- Product safety and quality concerns.
- Changes to labor or employment laws or regulations.
- Statutory, regulatory, and legal developments, including those related to tax or privacy.
- Evolving corporate governance and public disclosure regulations and expectations (e.g., cybersecurity and environmental, social, and governance matters).
- Dependence on cash flows and net earnings generated during the fourth fiscal quarter (holiday shopping season).
- Constraints in the capital markets and changes to vendor credit terms or credit ratings.
- Failure to meet financial-performance guidance or other forward-looking statements.
Future Outlook
The company expects to reduce its traditional Domestic Best Buy store count by 5 stores in fiscal 2026 in the normal course of operations. Additional closures of select non-traditional Domestic store locations are expected in fiscal 2027 as part of restructuring initiatives. The company does not expect to incur material future restructuring charges related to the Fiscal 2026 Labor and Store Optimization Initiative or the Best Buy Health Optimization and China Sourcing Initiative. Restructuring accrual liabilities for termination benefits of $63 million (Fiscal 2026 Labor and Store Optimization) and $56 million (Fiscal 2024 Restructuring) reflect expected future cash payments primarily during fiscal 2027. Restructuring accrual liabilities for termination benefits of $15 million (Best Buy Health Optimization) reflect expected future cash payments primarily during fiscal 2026. The company's long-term capital allocation strategy is to first fund operations and investments in growth, then return excess cash to shareholders through dividends and share repurchases while maintaining investment-grade credit metrics.
Management Comments
- "We are driven by our purpose to enrich lives through technology and our vision to personalize and humanize technology solutions for every stage of life."
- "We accomplish this by leveraging our combination of tech expertise and a human touch to meet our customers everyday needs, whether they come to us online, visit our stores or invite us into our homes."
- "Comparable sales changes in the third quarter and first nine months of fiscal 2026 primarily included comparable sales growth in computing, gaming and mobile phones, partially offset by comparable sales declines in home theater, appliances and drones."
- "A change in Best Buy Healths customer base during the quarter resulted in an impairment review of all Best Buy Health assets. The impairments reflect downward revisions of our revenue growth rates and margin rates compared to previous projections, in part due to pressures in the Medicaid and Medicare Advantage markets."
Industry Context
The filing highlights a mixed retail environment, with growth in certain technology categories like computing, gaming, and mobile phones, reflecting ongoing consumer demand for new innovations. However, declines in categories like home theater and appliances suggest broader consumer spending caution or shifts in discretionary spending. The challenges faced by Best Buy Health, particularly pressures in the Medicaid and Medicare Advantage markets, indicate difficulties in the health tech sector, which may be experiencing increased competition or regulatory hurdles. The company's focus on an omni-channel customer experience aligns with broader retail trends of integrating online and in-store shopping.
Comparison to Industry Standards
- NA
Legal Proceedings
- The company is involved in a number of legal proceedings. Accruals have been made where appropriate, but liability is not probable or cannot be reasonably estimated in all cases. Disclosure is provided for matters where the impact is reasonably possible to be material to the Condensed Consolidated Financial Statements.
Stakeholder Impact
- Shareholders: Experienced a significant decrease in diluted EPS and net earnings, though the company continues share repurchases and dividend payments.
- Employees: Affected by restructuring initiatives involving termination benefits and organizational changes, with some higher-than-expected employee retention noted.
- Customers: Benefit from continued focus on omni-channel experience and new technology innovation, but may see store closures in some areas.
- Suppliers: Participate in a supply chain financing program, allowing early accounts payable settlements.
- Creditors: The company maintains its credit facilities and manages long-term debt, indicating stable access to capital.
Next Steps
- Continue to align field resources with changing customer behaviors.
- Close select non-traditional store locations.
- Redirect corporate resources for better alignment with strategy.
- Optimize the Best Buy Health business to maximize value and improve profitability.
- Reduce exposure to tariffs, particularly in China.
- Reduce traditional Domestic Best Buy store count by 5 stores in fiscal 2026.
- Additional closures of select non-traditional Domestic store locations expected in fiscal 2027.
- Include updated income tax disclosures in the fiscal 2026 Form 10-K.
- Include updated expense disclosures in the fiscal 2028 Form 10-K.
Key Dates
| Date | Description |
|---|---|
| February 28, 2022 | Board of Directors approved a $5.0 billion share repurchase program. |
| April 2023 | Previous $1.25 billion senior unsecured revolving credit facility was entered into. |
| February 3, 2024 | Balances at beginning of nine months ended November 2, 2024. |
| February 1, 2025 | Fiscal year end for Annual Report on Form 10-K; Balance Sheet date. |
| April 18, 2025 | Entered into a new $1.25 billion five-year senior unsecured revolving credit facility agreement, replacing the previous facility. |
| July 4, 2025 | President Trump signed the One Big Beautiful Bill Act (OB3) into law. |
| August 2, 2025 | Balances at beginning of three months ended November 1, 2025. |
| August 3, 2025 | Start of share repurchase period for Q3 FY26. |
| November 1, 2025 | End of the quarterly period for this 10-Q filing; Balance Sheet date. |
| December 3, 2025 | Number of common shares outstanding reported. |
| December 5, 2025 | Filing date of the Quarterly Report on Form 10-Q. |
| December 15, 2024 | Effective date for ASU 2023-09 (Income Taxes) for annual periods. |
| April 2028 | Scheduled expiration of the previous revolving credit facility. |
| October 1, 2028 | Maturity date for $500 million principal amount of notes. |
| April 2030 | Expiration date of the new Five-Year Facility Agreement. |
| October 1, 2030 | Maturity date for $650 million principal amount of notes. |
| December 15, 2026 | Effective date for ASU 2024-03 (Income Statement Expenses) for fiscal years. |
| December 15, 2027 | Effective date for ASU 2024-03 (Income Statement Expenses) for interim periods. |
Recommendation
holdWhile Best Buy demonstrated revenue growth and positive comparable sales, the significant decline in net earnings and diluted EPS, primarily driven by substantial goodwill and intangible asset impairments related to Best Buy Health and increased restructuring charges, indicates ongoing challenges. The company is actively addressing these issues through optimization initiatives and store adjustments, which are necessary for long-term health. However, the immediate impact on profitability suggests a 'hold' position until these strategic changes demonstrate a clear and sustained positive effect on the bottom line and the Best Buy Health segment stabilizes. The improved operating cash flow and continued capital returns are positive, but the impairment charges signal a need for caution.
Keywords
Best Buy, BBY, Quarterly Report, 10-Q, Retail, Consumer Electronics, Financial Results, Earnings, Comparable Sales, Goodwill Impairment, Restructuring, Best Buy Health, E-commerce, Omni-channel, Share Repurchase, Dividends, Supply Chain, Fiscal 2026
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.